Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106092614 | 10609261 | 4 | F | 20141116 | 20160623 | 20141126 | 20160701 | EXP | CA-MERCK-1411CAN011413 | MERCK | 63.98 | YR | M | Y | 0.00000 | 20160701 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106092614 | 10609261 | 1 | PS | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 10 MG DAILY | 20829 | 10 | MG | TABLET | QD | ||||||
| 106092614 | 10609261 | 2 | SS | SINGULAIR | MONTELUKAST SODIUM | 1 | 20829 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106092614 | 10609261 | 1 | Asthma |
| 106092614 | 10609261 | 2 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106092614 | 10609261 | DE |
| 106092614 | 10609261 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106092614 | 10609261 | Chronic obstructive pulmonary disease | |
| 106092614 | 10609261 | Dyspnoea | |
| 106092614 | 10609261 | Intestinal obstruction | |
| 106092614 | 10609261 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |